Mach7 Technologies (ASX:M7T) — Material Events
ASX:M7T · 14 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Mach7 Powers Veterans Health Teleradiology Program LaunchMedium
Mach7 Technologies Launches Phase 1 of Veterans Health Administration National Teleradiology Program
31 Oct 2025
·Contract Announcement
·85
Mach7 Technologies Narrows Loss, Boosts Subscription Revenue Amid CEO TransitionMedium
Mach7 Technologies posts 16% revenue growth, narrows loss, shifts to subscription model, appoints new CEO
27 Aug 2025
·Preliminary Final Report & Directors’ Report and Audited Financial Statements
·85
Mach7 Narrows Losses and Gears Up for Strategic Shift in FY26Medium
Mach7 FY25 revenue up 16%, adjusted EBITDA loss narrows, positive NPATA, strategic review underway
27 Aug 2025
·Full Year Results
·80
Mach7 Technologies Charts Growth with New CEO and Strong FY25 OutlookMedium
Mach7 Technologies reports Q4 FY25 results, updates FY25 guidance, and appoints Teri Thomas as new CEO
29 July 2025
·Quarterly Results Presentation
·80
Mach7 Strengthens Position with FY25 Growth and Strategic Leadership ShiftMedium
Mach7 posts strong FY25 results with positive cash flow, leadership changes, and reaffirmed guidance
29 July 2025
·Quarterly Business Update and Appendix 4C
·80
Mach7 Technologies Accelerates Growth with 16% Revenue Rise and Strategic ShiftMedium
Mach7 posts 16% revenue growth, positive cash flow, leadership changes, and strategic review underway
27 Aug 2025
·FY25 Result Presentation
·80
Mach7 Advances VHA Contract Amid Strategic Reset and Leadership ShakeupMedium
Mach7 reports Q1 FY26 with key VHA contract go-live, leadership changes, and strategic reset
31 Oct 2025
·Quarterly Business Update and Appendix 4C
·75
Mach7 Technologies Secures First Flamingo Contract Amid Positive Cash Flow TurnaroundMedium
Mach7 Technologies posts positive cash flow, secures first Flamingo Architecture customer, and advances strategic growth initiatives in Q2 FY26
30 Jan 2026
·Quarterly Business Update and Appendix 4C
·75
Mach7 Secures $1M ARR Deal with UnityPoint Health for Flamingo ArchitectureMedium
Mach7 Signs 5-Year Flamingo Architecture Deal with UnityPoint Health, $1M ARR Expected
3 Dec 2025
·Contract Announcement
·75
Mach7 Technologies Faces Revenue Slide and Loss Surge Amid Strategic ResetMedium
Mach7 Technologies reports 23% revenue decline and widened loss in H1 FY26 amid strategic reset
27 Feb 2026
·Appendix 4D Half-year report
·Unexpected
·75
Mach7 Cuts Deployment Time with $1.7M AMRADNET DealMedium
Mach7 Signs A$1.7M Contract with AMRADNET, Cuts Deployment Time to 45 Days
20 May 2026
·Customer Contract Announcement
·75
Mach7 Technologies Advances AI Imaging Amid Strategic OverhaulMedium
Mach7 Technologies reports Q1 FY26 results with growth in ARR and strategic commercial transformation underway
31 Oct 2025
·Quarterly Results Presentation
·70
Mach7 Technologies Wraps Up $2.24M Share Buy-Back, Buys 6.27M SharesMedium
Mach7 Technologies completes $2.24M on-market share buy-back, acquiring 6.27M shares
4 Mar 2026
·Share Buy-Back Completion
·60
VHA Halts NextGen PACS Program, Mach7 Faces Contract SetbackMedium
VHA cancels NextGen PACS program; Mach7 contract partially stopped
23 Jan 2026
·Contract Update
·Unexpected
·60
No articles in this tier for the last 12 months.
Market Mentions
1
- appeared in market wrap coverage
These are market wrap articles where Mach7 Technologies (ASX:M7T) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026